summit clinical trial tirzepatide Pipeline Pulse: A look at tirzepatide, ziltivekimab and obicetrapib 408. Journal Club: The SUMMIT

Peter Attia 18 Feb 23 Lean mass loss on GLP-1 receptor agonists: a downside of the miracle drugs Clinical trials have generated impressive data on the effects of GLP-1 agonists on body weight and BMI, but how do these drugs perform in terms of body composition

This makes it quite expensive when used as a weight loss drug

Mounjaro injection: what users should know The Mounjaro injection is taken once a week

Tests are done similarly for region and industry: Northeast is compared to all firms NOT in the Northeast (an aggregate of firms in the Midwest, South, and West)

These pleiotropic benefits may be particularly valuable for patients with obesity, metabolic syndrome, or type 2 diabetes who have residual cardiovascular risk despite adequate statin therapy